IviGene Overview

  • Founded
  • 2000
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

IviGene General Information

Description

Owner and operator of a biotechnology company intended to facilitate genetic research for the study of antigens. The company's services focus on incorporating an In Vivo Induced Antigen Technology which uses antibodies present in the blood of patients infected with or recently recovered from infection with a particular pathogen and help generate and screen antibodies that serve as probes to screen a genomic expression library of the pathogen in order to identify proteins that are specifically expressed during an actual human infection, enabling medical researchers to develop and innovate drugs using antibodies for treating and curing chronic diseases and for vaccine diagnostic and pharmaceutical development.

Contact Information

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Primary Office
  • 12085 Research Drive
  • Alachua, FL 32615
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IviGene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 20-Nov-2006 000 Completed Startup
2. Corporate 12-Mar-2001 000 000 000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view IviGene’s complete valuation and funding history, request access »

IviGene Executive Team (3)

Name Title Board Seat Contact Info
Ann Perogulske-Fox Co-Founder
Jeffrey Hillman Ph.D Co-Founder & Chief Scientific Officer
Martin Handfield Ph.D Co-Founder
To view IviGene’s complete executive team members history, request access »

IviGene Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Xtl Biopharmaceuticals Corporation Minority 000 0000 000000 0
To view IviGene’s complete investors history, request access »